Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesPreferred Shares IssuedShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexicon Pharmaceuticals (LXRX) Change in Cash (2023 - 2025)

Lexicon Pharmaceuticals (LXRX) has disclosed Change in Cash for 6 consecutive years, with -$15.3 million as the latest value for Q4 2025.

  • Quarterly Change in Cash fell 147.75% to -$15.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$3.3 million through Dec 2025, down 107.54% year-over-year, with the annual reading at -$3.3 million for FY2025, 107.54% down from the prior year.
  • Change in Cash for Q4 2025 was -$15.3 million at Lexicon Pharmaceuticals, down from $28.3 million in the prior quarter.
  • The five-year high for Change in Cash was $76.3 million in Q2 2023, with the low at -$81.2 million in Q3 2023.
  • Average Change in Cash over 3 years is $1.4 million, with a median of -$2.4 million recorded in 2024.
  • The sharpest move saw Change in Cash plummeted 179.82% in 2024, then soared 2754.03% in 2025.
  • Over 3 years, Change in Cash stood at $1.3 million in 2023, then surged by 2279.91% to $32.1 million in 2024, then plummeted by 147.75% to -$15.3 million in 2025.
  • According to Business Quant data, Change in Cash over the past three periods came in at -$15.3 million, $28.3 million, and -$12.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.